Consolidated Edison, Inc. (NYSE:ED)
| CAPS Rating |
|
|---|---|
| Open | $59.33 |
| Previous Close | $59.47 |
| Daily Range | $59.00 - $59.44 |
| 52-Week Range | $48.55 - $62.74 |
| Market Cap | $17.32B |
| P/E Ratio | 15.70 |
| Dividend (Yield) | 2.42 (5.40%) |
| Volume | 1,800,685 |
| Average Daily Volume | 0 |
How do you think ED will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ED Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ED News and Commentary
- 10 High-Yield S&P 500 Dividend Stocks With Growing Dividends – Blog at The Motley Fool
- This Stock Isn't Inflated by the Dividend Bubble – The Motley Fool
- Do These Stocks Have Everything You Want? – The Motley Fool
- Dividend Bubble? – The Motley Fool
- Is Consolidated Edison Good Enough for You? – The Motley Fool
- Which Energy Company Could Spark Your Returns? – Blogs @ The Motley Fool
- Utilities Stock Funds Were 2011's Bright Star – Blog at The Motley Fool
- It's Lights Out For Utilities Investors – The Motley Fool
- Consolidated Edison Beats Analyst Estimates on EPS – The Motley Fool
- Con Edison Posts Mixed Numbers - Analyst Blog – NASDAQ
- ConEd 4Q Profit Drops On Mark-To-Market Effects – SmartMoney
- The Big Question: Is the World Underinvested in U.S. Stocks? – The Motley Fool
- Consolidated Edison: Dividend Dynamo or Blowup? – The Motley Fool
- Vivus' ED Drug Continues to Hold Up - Analyst Blog – NASDAQ
- Why Companies Can Shun Dividends – The Motley Fool
- New York Officials Discuss Future Of Indian Point Nuclear Plant – SmartMoney
- Vivus' Obesity Drug Label Modified - Analyst Blog – NASDAQ
- Utility Stocks: A Good Bet in 2012? - Analyst Blog – NASDAQ
- More Proof That Companies Shun Dividends at Their Own Peril – The Motley Fool
- Analysts' Picks No Better Than Throwing Darts – SmartMoney

RSS Headlines
Fool UK